Structure | Compound Name | Standard Type | Standard Values (in nM) |
|---|---|---|---|
| Darapladib | IC50 | 0.25 [1] | |
| Darapladib | Ki | 0.11 [1] | |
| 8-Hydroxy-4-oxo-N-phenyl-1H-quinoline-2-carboxamide | IC50 | 74.0 [1] | |
| 8-(Methanesulfonamido)-4-oxo-N-phenyl-1H-quinoline-2-carboxamide | IC50 | 27.0 [1] | |
| N-[2-(Diethylamino)ethyl]-2-[2-[(4-fluorophenyl)methylsulfanyl]-5-[(1-methylpyrazol-4-yl)methyl]-4-oxopyrimidin-1-yl]-N-[[4-[4-(trifluoromethyl)phenyl]phenyl]methyl]acetamide | IC50 | 0.01 [1], 0.06 [2], 3.0 [3] | |
MLA | "Quest Database™ LDL-associated phospholipase A2 Inhibitors (IC50, Ki)." AAT Bioquest, Inc., 4 Dec. 2025, https://www.aatbio.com/data-sets/ldl-associated-phospholipase-a2-inhibitors-ic50-ki. | |
APA | AAT Bioquest, Inc. (2025, December 4). Quest Database™ LDL-associated phospholipase A2 Inhibitors (IC50, Ki). AAT Bioquest. https://www.aatbio.com/data-sets/ldl-associated-phospholipase-a2-inhibitors-ic50-ki. | |
| BibTeX | EndNote | RefMan |